Navigation Links
Thomson Reuters Joins the InChI Trust
Date:8/18/2009

PHILADELPHIA and LONDON, Aug. 18 /PRNewswire/ --Thomson Reuters today announced that they have joined the InChI Trust, a not-for-profit organization to expand and develop the InChI Open Source chemical structure representation algorithm. The algorithm provides a consistent, credible and compatible way for databases of chemical structures to be linked together for the benefit of users of chemical information around the world.

"We are committed to supporting the InChI Trust and InChI initiative," said Dr. Josep Prous, Jr., Vice President and Chief Scientific Officer at Thomson Reuters. "The latest version of Prous Science Integrity(R) drug discovery database adds InChI's and InChIKeys to the more than 370,000 drugs and intermediates covered, facilitating access to and communication of information in the chemistry community."

Support of the InChI initiative and the adoption of InChI's within Prous Science Integrity(R) will further chemistry users' ability to integrate information across multiple sources and communicate this information in a consistent way across the globe.

"We are delighted to welcome Thomson Reuters as a member of the InChI Trust," says Project Leader Dr. Stephen Heller. "We value their support, as specialists within the chemical information industry, to continue to develop the InChI and InChIKey standards to enable wide scale linking of chemical information."

Prous Science Integrity seamlessly integrates biological, chemical and pharmacological information on more than 300,000 compounds with demonstrated biological activity, plus tens of thousands of synthesis intermediates and over 125,000 patent family records. Updated daily, this unique database is designed to empower your drug discovery and development activities. Find out more about Prous Science Integrity here.

Thomson Reuters will be attending the 238(th) American Chemical Society's National Meeting and Exposition, August 16-20, 2009 in Washington, DC and ChemOutsourcing, September 14-16, 2009 in Long Branch, NJ. Researchers are encouraged to come and receive a demonstration of the latest changes to Prous Science Integrity.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Thomson Reuters Announces 2009 Edition of the CMR International Pharmaceutical R&D Factbook
2. Thomson Reuters Partners With Sagient Research
3. Brazils Scientific Research On The Rise, Thomson Reuters Study Finds
4. Thomson Reuters Makes Disease Briefing on Influenza Covering H1N1 (Swine Flu) Publicly Available
5. Thomson Reuters Examines Highly Cited Research in Bioterrorism
6. Thomson Reuters Commemorates World IP Week with Series of Strategic Intellectual Property Seminars Across the U.S.
7. APS Healthcare and Thomson Reuters to Manage New York States Medicaid Clinical Best Practices Review Program
8. Thomson Reuters Names Hottest Researchers and Papers of 2007-2008
9. Despite Decline in Share of Global Output, U.S. Science Impact Still Strong, Says Thomson Reuters
10. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
11. The Scientific Business of Thomson Reuters Publishes Its 2008 Liquent Regulatory Affairs Trends Survey Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
Breaking Biology Technology:
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
Breaking Biology News(10 mins):